News
'Plan S' and 'cOAlition S': joining forces to accelerate the transition to Open Access
On 4 September, Commissioner Moedas – who is in charge of Research, Science and Innovation – announced the launch of 'Plan S' and 'cOAlition S'. With this initiative, a coalition of national research funders from France, Great Britain, Sweden, Norway, Austria, Ireland, Luxembourg, Poland, Slovenia and the Netherlands, supported by the Commission, have committed to accelerating the transition to open access.
The latest in a stream of new members
Avicenna Alliance is happy to announce the newest addition to its list of members: Optimo Medical AG. The Alliance is happy to welcome this Swiss-based European company as a member and increase its presence in the biomechanical industry.
EU Commission steps up support for personalised medicine
In the past months, the EU has presented several initiatives that jointly have the potential to advance personalised medicine in Europe. Next to a proposal published in June 2018 for a reformed research programme, several initiatives have been announced that promote data sharing and the further development of High Performance Computing and Artificial Intelligence.
In vivo, in vitro, in silico: Why computer modelling is the next evolution of the healthcare sector
International Conference on In Silico Medicine on 4 September
Cipla brings India perspectives on In Silico to Brussels
New Avicenna Member company Cipla shared some key insights on India’s perspective of In Silico medicine during a visit to Brussels in April. Mr. Nandan Kulkarni, Associate Director representing the company, used this opportunity to meet with representatives of the Avicenna Alliance to discuss Computer Modelling and Simulation in India and the European Union (EU).
Enabling the digital transformation of health and care in the EU
The European Commission presented its views on e-health and proposed a set of measures to facilitate the digital transformation of health and care in a Communication published on 25 April. It sets out how digital innovations can be used to promote health, prevent and control diseases, help address patients' unmet needs and make it easier for citizens to have equal access to high quality care.
